More recently, they have emerged as effective treatments for obesity—slowing digestion, increasing feelings of fullness, and reducing hunger. But while the benefits of GLP-1 receptor agonists ...
By Gina Kolata The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped ... drugs because it binds to GLP-1 receptors, using two peptides that stick ...
The data showed that those who received semaglutide had a reduced incidence of death from cardiovascular causes ... newer obesity/diabetes treatment that, unlike semaglutide, is a dual receptor ...